Brad Rybinski

400 total citations
10 papers, 277 citations indexed

About

Brad Rybinski is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Brad Rybinski has authored 10 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Brad Rybinski's work include Hedgehog Signaling Pathway Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Glioma Diagnosis and Treatment (2 papers). Brad Rybinski is often cited by papers focused on Hedgehog Signaling Pathway Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Glioma Diagnosis and Treatment (2 papers). Brad Rybinski collaborates with scholars based in United States. Brad Rybinski's co-authors include Janusz Franco‐Barraza, Edna Cukierman, Kyuson Yun, Roderick T. Bronson, Benjamin E. Low, Michael D. Taylor, David Shih, Daniel A. Weiser, Mehmet H. Kocoglu and Dong‐Mi Shin and has published in prestigious journals such as PEDIATRICS, Cancer Research and Oncotarget.

In The Last Decade

Brad Rybinski

10 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brad Rybinski United States	5	113	108	53	44	35	10	277
Zhujun Li China	8	87 0.8×	92 0.9×	44 0.8×	35 0.8×	59 1.7×	33	320
Alice Paulitti Italy	5	62 0.5×	176 1.6×	77 1.5×	45 1.0×	43 1.2×	6	317
Karen Gambaro Canada	11	114 1.0×	266 2.5×	65 1.2×	39 0.9×	19 0.5×	18	384
Giulia Tarticchio Italy	5	60 0.5×	182 1.7×	74 1.4×	48 1.1×	53 1.5×	5	324
Pugazendhi M Erusappan Norway	7	153 1.4×	162 1.5×	82 1.5×	73 1.7×	63 1.8×	9	381
Naoya Takahashi Japan	6	58 0.5×	117 1.1×	47 0.9×	26 0.6×	29 0.8×	7	228
Jessie Brown United States	7	137 1.2×	192 1.8×	64 1.2×	42 1.0×	85 2.4×	11	344
Danny Gerrits Netherlands	8	125 1.1×	127 1.2×	49 0.9×	23 0.5×	31 0.9×	11	301
Angela R. Blissett United States	8	77 0.7×	126 1.2×	36 0.7×	50 1.1×	36 1.0×	11	396
Hirotsugu Yanai Japan	13	160 1.4×	201 1.9×	93 1.8×	24 0.5×	48 1.4×	24	454

Countries citing papers authored by Brad Rybinski

Since Specialization

Citations

This map shows the geographic impact of Brad Rybinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Rybinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Rybinski more than expected).

Fields of papers citing papers by Brad Rybinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Rybinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Rybinski. The network helps show where Brad Rybinski may publish in the future.

Co-authorship network of co-authors of Brad Rybinski

This figure shows the co-authorship network connecting the top 25 collaborators of Brad Rybinski. A scholar is included among the top collaborators of Brad Rybinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad Rybinski. Brad Rybinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

George, Joshy, Yaohui Chen, Nourhan Abdelfattah, et al.. (2022). Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors. Cancer Research Communications. 2(6). 402–416. 5 indexed citations

Rybinski, Brad, Aaron P. Rapoport, Ashraf Badros, Nancy M. Hardy, & Mehmet H. Kocoglu. (2022). Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era. Clinical Lymphoma Myeloma & Leukemia. 22(8). e716–e729. 3 indexed citations

Rybinski, Brad & Mehmet H. Kocoglu. (2021). Hepatic AL Amyloidosis Without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab. American Journal of Case Reports. 22. e933241–e933241. 2 indexed citations

Rybinski, Brad, et al.. (2020). Preclinical Metrics Correlate With Drug Activity in Phase II Trials of Targeted Therapies for Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 587377–587377. 1 indexed citations

Rybinski, Brad, et al.. (2020). An 8-Year-Old Boy With Fever, Splenomegaly, and Pancytopenia. PEDIATRICS. 146(1). 4 indexed citations

Rybinski, Brad, et al.. (2019). Multifocal primary neuroblastoma tumor heterogeneity in siblings with co‐occurring PHOX2B and NF1 genetic aberrations. Genes Chromosomes and Cancer. 59(2). 119–124. 6 indexed citations

Rybinski, Brad, et al.. (2018). Systemic manifestations of extraskeletal myxoid chondrosarcoma associated with a novel t(2;22)(q34;q12) EWS translocation in a child and a review of the literature. Pediatric Hematology and Oncology. 35(7-8). 434–441. 1 indexed citations

Rybinski, Brad & Kyuson Yun. (2016). Addressing intra-tumoral heterogeneity and therapy resistance. Oncotarget. 7(44). 72322–72342. 61 indexed citations

Chow, Kin-Hoe, Dong‐Mi Shin, Molly H. Jenkins, et al.. (2014). Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity. Cancer Research. 74(17). 4864–4874. 19 indexed citations

10.

Rybinski, Brad, Janusz Franco‐Barraza, & Edna Cukierman. (2014). The wound healing, chronic fibrosis, and cancer progression triad. Physiological Genomics. 46(7). 223–244. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact